Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  F-18 16 alpha-fluoroestradiol
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-10 of 10 for your search:
Start Over
Diagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer
Phase: Phase III
Type: Diagnostic
Status: Active
Age: 19 and over
Sponsor: Other
Protocol IDs: FES13001, NCT01986569
IMaging PAtients for Cancer Drug selecTion - Metastatic Breast Cancer
Phase: Phase II, Phase I
Type: Diagnostic, Health services research
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: IMPACT MBC, NCT01957332
PET/CT Guided Fulvestrant Therapy for Patients With Recurrent or Metastatic Breast Cancer
Phase: Phase II
Type: Diagnostic, Treatment
Status: Active
Age: 45 and over
Sponsor: Other
Protocol IDs: PET/CT Breast, NCT00816582
AR and ER Imaging in Metastatic Breast Cancer
Phase: Phase II
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2012.2708, NCT01988324
FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy
Phase: Phase II
Type: Diagnostic
Status: Approved-not yet active
Age: 19 and over
Sponsor: NCI
Protocol IDs: NCI-2015-00383, EAI142, U10CA180820, NCT02398773
[18F]FES PET/CT in Endocrine Refractory Breast Cancer
Phase: Phase II
Type: Diagnostic
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: 821717, NCT02409316
Fluoroestradiol PET Imaging in Predicting Response to Hormone Therapy of Breast Cancer
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: P110113, IDRCB, NCT01627704
Fluorestradiol (FES) PET/CT for Imaging Estrogen Receptor Status
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 13-071, NCT01916122
F-18 FES PET in Measuring Hormone Expression in Patients With Primary, Recurrent or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 7184, NCI-2013-02342, P01CA042045, P30CA015704, NCT02149173
18F-FES PET/CT in Imaging Patients With Desmoid Tumors
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: VICC SAR 1458, NCI-2015-00081, P30CA068485, NCT02374931
Start Over